OVAWATCH

Serial Number 99033080
Registration 7836210
700

Registration Progress

Application Filed
Feb 7, 2025
Under Examination
Approved for Publication
Apr 29, 2025
Published for Opposition
Apr 29, 2025
Registered
Jun 17, 2025

Trademark Image

OVAWATCH

Basic Information

Serial Number
99033080
Registration Number
7836210
Filing Date
February 7, 2025
Registration Date
June 17, 2025
Published for Opposition
April 29, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 17, 2025
Registration
Registered
Classes
005

Rights Holder

Aspira Women's Health Inc.

03
Address
12117 Bee Caves Road Building III, Suite 100
Austin, TX 78738

Ownership History

Aspira Women's Health Inc.

Original Applicant
03
Austin, TX

Aspira Women's Health Inc.

Owner at Publication
03
Austin, TX

Aspira Women's Health Inc.

Original Registrant
03
Austin, TX

Legal Representation

Attorney
Melissa Hunter-Ensor

USPTO Deadlines

Next Deadline
2150 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-17)
Due Date
June 17, 2031
Grace Period Ends
December 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

11 events
Date Code Type Description Documents
Jun 17, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 17, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 29, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 29, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 23, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 1, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 31, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 30, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 30, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 7, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 7, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Reagents for medical use; Diagnostic preparations for medical purposes
First Use Anywhere: 20221100
First Use in Commerce: 20221100

Additional Information

Design Mark
The mark consists of the term "OVAWATCH" in stylized font with a magnifying glass integrated into the letter "C" and the handle continuing on an angle to the left below.

Classification

International Classes
005